E phage gene transfection enhances sensitivity of lung and colon cancer cells to chemotherapeutic agents (original) (raw)
674. Insertional Mutagenesis to Identify Mechanisms of Cetuximab Resistance in Colorectal Cancer
Valentina Pirazzoli
Molecular Therapy, 2016
View PDFchevron_right
Key genes and drug delivery systems to improve the efficiency of chemotherapy
Louis Jean Delinois
Cancer Drug Resistance, 2020
View PDFchevron_right
The cytotoxic activity of the phage E protein suppress the growth of murine B16 melanomas in vitro and in vivo
Antonio Martínez-Amat
Journal of Molecular Medicine, 2009
View PDFchevron_right
Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector
Gary Reynolds
View PDFchevron_right
Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954
David Kerr
Gene Therapy, 1998
View PDFchevron_right
Combination of esomeprazole with chemotherapeutics results in more pronounced cytotoxic effect via apoptosis on A549 nonsmall-cell lung cancer cell line
Engin Ulukaya, Barbaros Oral
View PDFchevron_right
Excellent In vivo Bystander Activity of Fludarabine Phosphate against Human Glioma Xenografts that Express the Escherichia coli Purine Nucleoside Phosphorylase Gene
Dana Levasseur
Cancer Research, 2004
View PDFchevron_right
Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines
Paul Bunn
Cancer research, 1999
View PDFchevron_right
Antitumor activity of 2-fluoro-2′-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase
Abdalla Hassan
Cancer Gene Therapy, 2003
View PDFchevron_right
Drugs targeting the mitochondrial pore act as citotoxic and cytostatic agents in temozolomide-resistant glioma cells
Leonardo Rossi
Journal of Translational Medicine, 2009
View PDFchevron_right
Antitumor effect of combination of the inhibitors of two new oncotargets: proton pumps and reverse transcriptase
Stefano Fais
Oncotarget, 2017
View PDFchevron_right
Inhibition of nucleotide excision repair and sensitisation of cells to DNA cross-linking anticancer drugs by F 11782, a novel fluorinated epipodophylloid
Jean-Marc Barret
Biochemical Pharmacology, 2002
View PDFchevron_right
Paclitaxel-2′-Ethylcarbonate Prodrug Can Circumvent P-glycoprotein-mediated Cellular Efflux to Increase Drug Cytotoxicity
Chenhong Luo
Pharmaceutical Research, 2007
View PDFchevron_right
Increased Sensitivity to Cisplatin in Non-Small Cell Lung Cancer Cell Lines after FHIT Gene Transfer
Paola Perego
Neoplasia, 2006
View PDFchevron_right
Combined therapy using suicide gef gene and paclitaxel enhances growth inhibition of multicellular tumour spheroids of A-549 human lung cancer cells
Houria Boulaiz
International journal of oncology, 2008
View PDFchevron_right
Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer
Edward E Knaus
Gene Therapy, 1997
View PDFchevron_right
Generation of cytotoxic agents by targeted enzymes
Ingegerd Hellstrom
Bioconjugate Chemistry, 1993
View PDFchevron_right
Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: A tangible union against chemoresistant cancer
S. Joshi, Pamela Russell
BMC Cancer, 2011
View PDFchevron_right
In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells
Che-ming Teng
British Journal of Pharmacology, 2014
View PDFchevron_right
Excellent In vivo Bystander Activity of Fludarabine Phosphate against Human Glioma Xenografts that Express the Escherichia coli Purine Nucleoside Phosphorylase Gene
Dana Levasseur
View PDFchevron_right
Combination of thymidine phosphorylase gene transfer and deoxyinosine treatment greatly enhances 5-fluorouracil antitumor activity in vitro and in vivo
Athanassios Iliadis
Molecular cancer therapeutics, 2001
View PDFchevron_right
Mitochondrion as a Novel Target of Anticancer Chemotherapy
Etienne Jacotot
Journal of the National Cancer Institute, 2000
View PDFchevron_right
Differential genotoxic effects of antitumor trans-[PtCl2(E-iminoether)2] and cisplatin in Escherichia coli
Giovanni Natile, O. Novakova
Journal of Inorganic Biochemistry, 2002
View PDFchevron_right
Biotechnological and gene therapeutic strategies in cancer treatment
Bernd Groner
Gene, 1995
View PDFchevron_right
Compound, in Human Cancer Cells
Eric Raymond
2016
View PDFchevron_right
Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity
Keizo Takenaga
Cancer Gene Therapy, 2000
View PDFchevron_right
Drugs targeting mitochondrial functions to control tumor cell growth
Christian BAILLY
Biochemical Pharmacology, 2005
View PDFchevron_right
N′1,N′3-Dimethyl-N′1,N′3-bis(phenylcarbonothioyl) Propanedihydrazide (Elesclomol) Selectively Kills Cisplatin Resistant Lung Cancer Cells through Reactive Oxygen Species (ROS)
vy đinh
Cancers, 2009
View PDFchevron_right